R&D

Management Reshuffle at GlaxoSmithKline

Teva Confirms Massive Cost Cuts, Job Losses

Bayer Combines Pharma R&D in one Unit

UK Life Science Boom despite Brexit?

Teva Realigns, may Slash 25% of Workforce

FDA Approves new Two-drug HIV Treatment

Sasol Refocuses, Exits Shale and GTL

Kemira Invests in Oil Recovery Polymers

Venezuela: Plenty of Room for Improvement

Swiss Biotech Sector Stimulates Growth

Fostering Innovation

Trade and Industry Investment of the US Chemical Sector

The Middle East – More Opportunities than Risks

Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit

The Italian Chemical Industry

Green Chemistry and Smart Chemistry

The German Capital Region

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500 companies in the pharma, the biotech and the medtech industry.

Germany’s Chemical Industry: Steeled for Competition

Regaining Competitiveness in the Global Market

Sanofi, Principia to Develop MS Candidate

Covestro Leads CO2 Feedstock Research Project

Indorama Takes DuPont Teijin Films

Merck Gains Rights to KalVista’s Ocular Therapy

Both Positive and Negative Effects

Trinseo Opens R&D Center in the Netherlands

Ensuring Better Efficiency and Consistency

Pharma R&D Productivity Needs Improvement

Confidentiality is a Potential Pitfall

Consolidation is here to Stay

Changes in Portfolios and Pipelines are Likely

Setting High Standards

A Partner to Relieve the Strain

M&A in Pharma and CRO/CMO Industry

Digital’s Transformative Power across R&D

Innovative Companies Have to Deal with Risks